Labcorp at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
Labcorp takes part in 2 sessions at CTAD 2026 in Boston. Its program draws on real-world laboratory data on Alzheimer's blood tests. Its work covers how p-tau217 testing is used in practice, variability by APOE genotype and how p-tau217 and the amyloid-beta 42/40 ratio relate over time.
| Organization | CTAD 2026 Attendance |
|---|---|
Labcorp Burlington, North Carolina | ◇Silver Sponsor |
Laboratory testing and drug development company; offers blood p-tau217 testing for Alzheimer's and real-world data drawn from lab results. | Poster Wed Nov 18 7:15am–5:30pm Poster Thu Nov 19 7:15am–5:00pm |
Instantly find 20 buyers from Labcorp
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction